MedTrace Logo

Pharmacokinetics of Advantage Arrest

NCT04184271 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-01-26

Study results available
· View outcomes & findings →

Summary

The study aim is to characterize the kinetics of silver and fluoride after topical application of silver diamine fluoride.

Conditions

  • Dental Caries

Interventions

DRUG

38% silver diamine fluoride

Topical application of SDF to teeth

Sponsors & Collaborators

Principal Investigators

  • Peter Milgrom, DDS · University of Washington

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-09-30
Completion
2019-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184271 on ClinicalTrials.gov